1. Home
  2. LXEO vs FDBC Comparison

LXEO vs FDBC Comparison

Compare LXEO & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • FDBC
  • Stock Information
  • Founded
  • LXEO 2017
  • FDBC 1902
  • Country
  • LXEO United States
  • FDBC United States
  • Employees
  • LXEO N/A
  • FDBC N/A
  • Industry
  • LXEO
  • FDBC Major Banks
  • Sector
  • LXEO
  • FDBC Finance
  • Exchange
  • LXEO Nasdaq
  • FDBC Nasdaq
  • Market Cap
  • LXEO 314.1M
  • FDBC 322.7M
  • IPO Year
  • LXEO 2023
  • FDBC N/A
  • Fundamental
  • Price
  • LXEO $6.29
  • FDBC $53.49
  • Analyst Decision
  • LXEO Strong Buy
  • FDBC
  • Analyst Count
  • LXEO 7
  • FDBC 0
  • Target Price
  • LXEO $22.71
  • FDBC N/A
  • AVG Volume (30 Days)
  • LXEO 623.4K
  • FDBC 11.7K
  • Earning Date
  • LXEO 11-13-2024
  • FDBC 10-23-2024
  • Dividend Yield
  • LXEO N/A
  • FDBC 2.94%
  • EPS Growth
  • LXEO N/A
  • FDBC N/A
  • EPS
  • LXEO N/A
  • FDBC 2.68
  • Revenue
  • LXEO N/A
  • FDBC $71,243,000.00
  • Revenue This Year
  • LXEO N/A
  • FDBC N/A
  • Revenue Next Year
  • LXEO N/A
  • FDBC N/A
  • P/E Ratio
  • LXEO N/A
  • FDBC $20.26
  • Revenue Growth
  • LXEO N/A
  • FDBC N/A
  • 52 Week Low
  • LXEO $5.77
  • FDBC $41.10
  • 52 Week High
  • LXEO $22.33
  • FDBC $61.21
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 28.99
  • FDBC 49.27
  • Support Level
  • LXEO $5.77
  • FDBC $52.75
  • Resistance Level
  • LXEO $11.72
  • FDBC $56.05
  • Average True Range (ATR)
  • LXEO 0.85
  • FDBC 1.69
  • MACD
  • LXEO -0.19
  • FDBC -0.31
  • Stochastic Oscillator
  • LXEO 5.71
  • FDBC 19.92

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About FDBC Fidelity D & D Bancorp Inc.

Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers.

Share on Social Networks: